In May 2023, Guizhou Bailing announced that Jiang Wei, the controlling shareholder of the company, and his concerted actions transferred 65.438+63 billion shares of the company to China Resources Medicine, accounting for 654.38+00% of the company's total share capital. After the transaction is completed, China Resources Medicine will become the controlling shareholder of Guizhou Bailing, and China China Resources will become the indirect controlling shareholder of Guizhou Bailing.